During the past three years, Sam Rickenbach worked for several Portland-area companies as a cannabidiol (CBD) extraction laboratory director. He generally enjoyed his work, but over time came to believe that most of the businesses in his industry — including his own — were severely overcharging for their products.
The more and more he learned, the more disillusioned he became. He was bothered by the fact that many people with legitimate medical needs for CBD products were quite simply getting priced out of the market.